At close: December 20 at 4:27:51 PM GMT
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -0.02 | 0 |
| Low Estimate | 0 | 0 | -0.02 | 0 |
| High Estimate | 0 | 0 | -0.02 | 0 |
| Year Ago EPS | -- | -- | -0.04 | -0.02 |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.02 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SAR.L | -- | -- | 42.62% | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
VAL.L ValiRx plc
0.7250
0.00%
NFX.L Nuformix plc
0.0500
+0.50%
ROQ.L Roquefort Therapeutics plc
3.9500
+1.28%
PYC.L Physiomics Plc
0.7500
0.00%
IMM.L ImmuPharma plc
1.1950
-6.64%
LSB LakeShore Biopharma Co., Ltd
2.9600
+9.63%
SCLP.L Scancell Holdings plc
11.00
0.00%
SIGHT.PA GenSight Biologics S.A.
0.2775
+3.16%
SEELQ Seelos Therapeutics, Inc.
0.2700
+12.50%
FUM.L Futura Medical plc
31.95
-2.44%